相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarkers of Renal Tumors: the Current State and Clinical Perspectives
Marina O. Golovastova et al.
CURRENT UROLOGY REPORTS (2017)
Impact of targeted therapies in metastatic renal cell carcinoma on patient-reported outcomes: Methodology of clinical trials and clinical benefit
M. Dos Santos et al.
CANCER TREATMENT REVIEWS (2017)
Itch promotes the neddylation of JunB and regulates JunB-dependent transcription
Haiwen Li et al.
CELLULAR SIGNALLING (2016)
The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion
Ji-Gen Ping et al.
TUMOR BIOLOGY (2016)
MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma
Yi Zhang et al.
ONCOTARGET (2016)
Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells
Huiyin Lan et al.
SCIENTIFIC REPORTS (2016)
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study
Ronan T. Swords et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
Kuan-Lin Kuo et al.
CANCER LETTERS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting Neddylation Pathways to Inactivate Cullin-RING Ligases for Anticancer Therapy
Yongchao Zhao et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Thwarts Microenvironment-Driven NF-κB Activation and Induces Apoptosis in Chronic Lymphocytic Leukemia B Cells
J. Claire Godbersen et al.
CLINICAL CANCER RESEARCH (2014)
Overactivated Neddylation Pathway as a Therapeutic Target in Lung Cancer
Lihui Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles' heel in mantle cell lymphoma
M. A. Dengler et al.
CELL DEATH & DISEASE (2014)
The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis
Ping Xie et al.
NATURE COMMUNICATIONS (2014)
Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target
Qiang Gao et al.
ONCOTARGET (2014)
Disrupting Protein NEDDylation with MLN4924 Is a Novel Strategy to Target Cisplatin Resistance in Ovarian Cancer
Steffan T. Nawrocki et al.
CLINICAL CANCER RESEARCH (2013)
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
C. Mackintosh et al.
ONCOGENE (2013)
Radiosensitization of Human Pancreatic Cancer Cells by MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor
Dongping Wei et al.
CANCER RESEARCH (2012)
The Nedd8-Activating Enzyme Inhibitor MLN4924 Induces Autophagy and Apoptosis to Suppress Liver Cancer Cell Growth
Zhongguang Luo et al.
CANCER RESEARCH (2012)
MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy
Steffan T. Nawrocki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Inhibition of NEDD8-Activating Enzyme Induces Rereplication and Apoptosis in Human Tumor Cells Consistent with Deregulating CDT1 Turnover
Michael A. Milhollen et al.
CANCER RESEARCH (2011)
SCF E3 Ubiquitin Ligases as Anticancer Targets
L. Jia et al.
CURRENT CANCER DRUG TARGETS (2011)
Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort
Simon P. Kim et al.
JOURNAL OF UROLOGY (2011)
Quantitative Proteomic Analysis of Cellular Protein Modulation upon Inhibition of the NEDD8-Activating Enzyme by MLN4924
Hua Liao et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Induction of p21-Dependent Senescence by an NAE Inhibitor, MLN4924, as a Mechanism of Growth Suppression
Lijun Jia et al.
NEOPLASIA (2011)
NEDD8-Targeting Drug MLN4924 Elicits DNA Rereplication by Stabilizing Cdt1 in S Phase, Triggering Checkpoint Activation, Apoptosis, and Senescence in Cancer Cells
Jie Jessie Lin et al.
CANCER RESEARCH (2010)
Mechanism-Based Neddylation Inhibitor
Matthew D. Petroski
CHEMISTRY & BIOLOGY (2010)
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
James E. Brownell et al.
MOLECULAR CELL (2010)
RING Domain E3 Ubiquitin Ligases
Raymond J. Deshaies et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
DEPTOR Is an mTOR Inhibitor Frequently Overexpressed in Multiple Myeloma Cells and Required for Their Survival
Timothy R. Peterson et al.
CELL (2009)
Non-Clear Cell Renal Cancer: Features and Medical Management
Daniel Y. C. Heng et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Teresa A. Soucy et al.
NATURE (2009)
Novel substrates and functions for the ubiquitin-like molecule NEDD8
Dimitris P. Xirodimas
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival
J. James Bruno et al.
BJU INTERNATIONAL (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity
DP Xirodimas et al.
CELL (2004)
Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139
EP Rogakou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
